QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Pro-Dex (PDEX) Competitors

$16.55
-0.56 (-3.27%)
(As of 02/23/2024 ET)

PDEX vs. XAIR, SEPA, NVNO, NSPR, ICCM, CTCX, LUCD, DRIO, SRTS, and LNSR

Should you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Beyond Air (XAIR), SEP Acquisition (SEPA), enVVeno Medical (NVNO), InspireMD (NSPR), IceCure Medical (ICCM), Carmell (CTCX), Lucid Diagnostics (LUCD), DarioHealth (DRIO), Sensus Healthcare (SRTS), and LENSAR (LNSR). These companies are all part of the "surgical & medical instruments" industry.

Pro-Dex vs.

Pro-Dex (NASDAQ:PDEX) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, community ranking, risk, profitability, media sentiment and institutional ownership.

Beyond Air has a consensus price target of $11.25, suggesting a potential upside of 542.86%. Given Beyond Air's higher probable upside, analysts clearly believe Beyond Air is more favorable than Pro-Dex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Beyond Air
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Pro-Dex received 102 more outperform votes than Beyond Air when rated by MarketBeat users. However, 68.25% of users gave Beyond Air an outperform vote while only 60.42% of users gave Pro-Dex an outperform vote.

CompanyUnderperformOutperform
Pro-DexOutperform Votes
145
60.42%
Underperform Votes
95
39.58%
Beyond AirOutperform Votes
43
68.25%
Underperform Votes
20
31.75%

Pro-Dex has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.23, suggesting that its share price is 123% less volatile than the S&P 500.

In the previous week, Pro-Dex and Pro-Dex both had 2 articles in the media. Beyond Air's average media sentiment score of 0.49 beat Pro-Dex's score of -0.44 indicating that Beyond Air is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pro-Dex
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Beyond Air
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Pro-Dex has higher revenue and earnings than Beyond Air. Beyond Air is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pro-Dex$46.09M1.26$7.07M$0.7522.07
Beyond Air$870K72.49-$55.82M-$2.13-0.82

14.8% of Pro-Dex shares are owned by institutional investors. Comparatively, 30.6% of Beyond Air shares are owned by institutional investors. 42.6% of Pro-Dex shares are owned by insiders. Comparatively, 19.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Pro-Dex has a net margin of 5.59% compared to Beyond Air's net margin of 0.00%. Pro-Dex's return on equity of 8.97% beat Beyond Air's return on equity.

Company Net Margins Return on Equity Return on Assets
Pro-Dex5.59% 8.97% 5.40%
Beyond Air N/A -199.90%-106.00%

Summary

Pro-Dex beats Beyond Air on 10 of the 16 factors compared between the two stocks.


Get Pro-Dex News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDEX vs. The Competition

MetricPro-DexSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$58.09M$3.86B$5.03B$7.52B
Dividend YieldN/A2.03%2.92%3.86%
P/E Ratio22.0716.81101.2616.11
Price / Sales1.2624.803,103.9555.29
Price / Cash7.8630.9888.3852.42
Price / Book1.834.004.364.63
Net Income$7.07M$20.07M$112.59M$207.21M
7 Day Performance-6.29%-1.93%0.86%-0.98%
1 Month Performance-23.73%9.05%6.85%3.29%
1 Year Performance8.03%2.20%8.77%3.69%

Pro-Dex Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XAIR
Beyond Air
3.8543 of 5 stars
$1.77
-17.7%
$11.25
+535.6%
-68.6%$63.03M$870,000.00-0.8698Positive News
SEPA
SEP Acquisition
0 of 5 stars
$10.50
flat
N/A+13.2%$61.01MN/A0.00N/ANews Coverage
Gap Down
NVNO
enVVeno Medical
0 of 5 stars
$4.53
-6.6%
N/A+0.9%$60.34MN/A0.0019Positive News
Gap Up
NSPR
InspireMD
1.9229 of 5 stars
$2.79
+1.8%
$4.85
+73.8%
+133.9%$60.12M$5.17M-1.8455Analyst Report
Gap Down
ICCM
IceCure Medical
2.399 of 5 stars
$1.42
+2.2%
$3.50
+146.5%
+9.3%$64.78M$3.09M-3.8465Positive News
CTCX
Carmell
0 of 5 stars
$3.50
+7.4%
N/AN/A$67.34MN/A0.0014Upcoming Earnings
News Coverage
LUCD
Lucid Diagnostics
1.6233 of 5 stars
$1.25
flat
$3.25
+160.0%
-3.1%$55.84M$380,000.00-0.962,021Gap Down
DRIO
DarioHealth
2.7236 of 5 stars
$2.04
flat
$6.03
+195.8%
-56.9%$55.53M$27.66M-1.81241News Coverage
SRTS
Sensus Healthcare
1.5988 of 5 stars
$4.32
+2.9%
$7.50
+73.6%
-32.1%$70.76M$24.41M144.0542
LNSR
LENSAR
0.9789 of 5 stars
$4.72
+1.5%
$8.00
+69.5%
+51.7%$53.10M$35.36M-2.81110News Coverage
Positive News

Related Companies and Tools

This page (NASDAQ:PDEX) was last updated on 2/23/2024 by MarketBeat.com Staff